TY - JOUR
T1 - Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line
AU - Jiang, Wei Qin
AU - Szekely, Laszlo
AU - Klein, George
AU - Ringertz, Nils
N1 - Funding Information:
We thank Dr. Jerry Shay for the IDH4 cell line and for valuable discussions, Dr. David Lane for the rabbit anti-p53 and anti-SV40T antibodies, and Dr. Hugues de The for the rabbit anti-PML antibody. We are indebted to Ms. Ulla Krondahl and Evi Mellqvist for excellent technical assistance. We also thank Drs. Lars Wieslander, Thomas Sejersen, and Irene Hunter for fruitful advice. This research was supported by grants from the Swedish Medical Research Council, the Knut and Alice Wallenbergs Foundation, and the Karolinska Institutet.
PY - 1996/12/15
Y1 - 1996/12/15
N2 - We have previously reported that EBNA-5, one of the Epstein-Barr virus- encoded proteins, accumulates in the nuclear bodies containing PML, the promyelocytic leukemia associated protein. In this study, we examine the intranuclear distribution of SV40 large T-antigen (SV40T), the p53 tumor suppressor protein (p53), and PML in a conditionally immortalized cell line, IDH4. In IDH4 cells, the expression of SV40T is regulated by a dexamethasone (Dex)-driven promoter. Withdrawal of Dex results in down-regulation of SV40T and growth arrest, whereas addition of Dex to the growth-arrested cells results in up-regulation of SV40T and proliferation. In proliferating IDH4 cells, SV40T is concentrated in nuclear dots that are also positive for p53. Many of these dots are juxtaposed to PML positive structures but do not colocalize with them. After removal of Dex, SV40T-p53 dots gradually disappear, while the PML structures remain. Induction of SV40T in nonproliferating IDH4 cells causes a coordinated redistribution of SV40T and p53. The immunostaining for SV40T and p53 is first weak, then strong with a homogeneous distribution, and 3-4 days later becomes dot-like again. This reappearance of SV40T-p53 dots coincides with the recovery of proliferation in restimulated IDH4 cells. Also, the p53 pattern correlates with the SV40T pattern with regard to both morphology and intensity during both suppression and induction of SV40T. Taken together, our data suggest that (i) the level of p53 is coregulated with the level of SV40T in a dose-dependent fashion; (ii) the formation of SV40T-p53 nuclear dots correlates with the transformed phenotype; (iii) the SV40T-p53 dots localize preferentially to the neighborhood of PML bodies which are already present in normal cells.
AB - We have previously reported that EBNA-5, one of the Epstein-Barr virus- encoded proteins, accumulates in the nuclear bodies containing PML, the promyelocytic leukemia associated protein. In this study, we examine the intranuclear distribution of SV40 large T-antigen (SV40T), the p53 tumor suppressor protein (p53), and PML in a conditionally immortalized cell line, IDH4. In IDH4 cells, the expression of SV40T is regulated by a dexamethasone (Dex)-driven promoter. Withdrawal of Dex results in down-regulation of SV40T and growth arrest, whereas addition of Dex to the growth-arrested cells results in up-regulation of SV40T and proliferation. In proliferating IDH4 cells, SV40T is concentrated in nuclear dots that are also positive for p53. Many of these dots are juxtaposed to PML positive structures but do not colocalize with them. After removal of Dex, SV40T-p53 dots gradually disappear, while the PML structures remain. Induction of SV40T in nonproliferating IDH4 cells causes a coordinated redistribution of SV40T and p53. The immunostaining for SV40T and p53 is first weak, then strong with a homogeneous distribution, and 3-4 days later becomes dot-like again. This reappearance of SV40T-p53 dots coincides with the recovery of proliferation in restimulated IDH4 cells. Also, the p53 pattern correlates with the SV40T pattern with regard to both morphology and intensity during both suppression and induction of SV40T. Taken together, our data suggest that (i) the level of p53 is coregulated with the level of SV40T in a dose-dependent fashion; (ii) the formation of SV40T-p53 nuclear dots correlates with the transformed phenotype; (iii) the SV40T-p53 dots localize preferentially to the neighborhood of PML bodies which are already present in normal cells.
UR - http://www.scopus.com/inward/record.url?scp=17944385820&partnerID=8YFLogxK
U2 - 10.1006/excr.1996.0374
DO - 10.1006/excr.1996.0374
M3 - Article
C2 - 8986612
AN - SCOPUS:17944385820
SN - 0014-4827
VL - 229
SP - 289
EP - 300
JO - Experimental Cell Research
JF - Experimental Cell Research
IS - 2
ER -